tedinopathy of the achilles tendon
Conditions
Interventions
Trade Name: Aethoxysklerol
Product Name: Aethoxysclerol
Product Code: 9002-92-0
Pharmaceutical Form: Injection*
Pharmaceutical form of the placebo: Injection*
Route of administration of the placebo: I
Sponsors
Radiological dept. Aalborg Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients over the age of 18 with tendinopathy of the achilles tendon of minimum 3 month duration, ultrasould verified neovessels. Has undergone conservative treatment in the form of exentric training for 3 months. Informed consent. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Dementia, psykiatric disease, no neovessels on ultrasound or affection of more than 50% of the horizontal area of the tendon, conditions contraindicating the use of polidocanol or lidocaine, pregnancy/lactation, fertile females not using anticontraception, not physically able to participate,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Investigate if ultrasound guided injektion of policanol is an effective treatment for tendinopathy of the achilles tendon;Secondary Objective: ;Primary end point(s): Pain measured on a Visual Analogue Scale (VAS) during the activity level that normally causes pain of the tendon | — |
Countries
Denmark
Outcome results
None listed